<p>CARGO Therapeutics（納斯達克代碼：CRGX - 獲取免費報告）在週四發佈給投資者的研究報告中，被 HC Wainwright 的股票研究分析師將評級從 “買入” 下調至 “中性”，Marketbeat Ratings 報道。</p>
<p>獲取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
<ul>
<li>2024 年 IPO 觀察：哪些新股票將上市？</li>
</ul>
<p>其他一些股票分析師最近也對 CRGX 發佈了報告。Chardan Capital 在 11 月 13 日的研究報告中重申了 “買入” 評級，並對 CARGO Therapeutics 的股票設定了 28.00 美元的目標價。William Blair 在 11 月 26 日的報告中開始覆蓋 CARGO Therapeutics，並對該股票給予了 “跑贏大盤” 的評級。一位投資分析師對該股票給予了賣出評級，六位分析師則給予了持有評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，共識目標價為 15.00 美元。</p>
<p><strong>閲讀我們關於 CARGO Therapeutics 的最新研究報告</strong></p>
<h2>CARGO Therapeutics 股票表現</h2>
<p>納斯達克 CRGX 在週四開盤價為 13.19 美元。該公司的市值為 6.0714 億美元，市盈率為-3.10，貝塔值為 2.50。該股票的 50 日移動平均價為 14.83 美元，200 日移動平均價為 17.45 美元。CARGO Therapeutics 的年低為 10.91 美元，年高為 33.92 美元。</p>
<p>CARGO Therapeutics（納斯達克代碼：CRGX - 獲取免費報告）最近在 11 月 12 日發佈了季度財報。該公司報告季度每股收益為（0.88 美元），超出市場共識預期的（1.14 美元）0.26 美元。股票分析師平均預測 CARGO Therapeutics 在當前財年將發佈-3.73 美元的每股收益。</p>
<h2>機構資金流入和流出</h2>
<p>一些對沖基金最近對 CRGX 的持倉進行了調整。FMR LLC 在第三季度將其在 CARGO Therapeutics 的持股增加了 1.1%。FMR LLC 目前擁有 6,954,476 股該公司的股票，價值 1.2831 億美元，此前在上個季度購買了 77,508 股。RTW Investments LP 在第三季度將其在 CARGO Therapeutics 的持倉提高了 0.5%。RTW Investments LP 目前擁有 4,098,955 股該公司的股票，價值 7562.6 萬美元，此前在該期間購買了 20,833 股。Janus Henderson Group PLC 在第三季度將其在 CARGO Therapeutics 的股份增加了 1.8%。Janus Henderson Group PLC 目前擁有 2,675,285 股該公司的股票，價值 4933.5 萬美元，此前在上個季度購買了 46,659 股。Wellington Management Group LLP 在第三季度將其在 CARGO Therapeutics 的持股增加了 4.1%。Wellington Management Group LLP 目前擁有 2,042,723 股該公司的股票，價值 3768.8 萬美元，此前在該期間購買了 79,782 股。最後，State Street Corp 在第三季度將其在 CARGO Therapeutics 的股份增加了 11.7%。State Street Corp 目前擁有 839,861 股該公司的股票，價值 1549.5 萬美元，此前在上個季度購買了 88,000 股。目前 93.16% 的股票由機構投資者持有。</p>
<h2>關於 CARGO Therapeutics</h2>
<p>（獲取免費報告）</p>
<p>CARGO Therapeutics, Inc 是一家臨牀階段的生物技術公司，開發用於癌症患者的嵌合抗原受體（CAR）T 細胞療法。該公司的主導項目是 CRG-022，一種自體 CD22 CAR T 細胞產品候選藥物，旨在通過靶向 CD22 這一在 B 細胞惡性腫瘤中表達的替代腫瘤抗原來應對耐藥機制。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票，而不是 CARGO Therapeutics</li>
<li>股票市場行業：它們是什麼以及有多少個？</li>
<li>金佰利：在這位股息之王中獲得的絕佳機會</li>
<li>3 只小盤股具有巨大的回報潛力</li>
<li>5 只股票的收益率高於市場，剛剛提高了支付</li>
<li>使用 MarketBeat 股息收益率計算器</li>
<li>Arista Networks 的股票暴跌：投資者的買入機會？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 CARGO Therapeutics 嗎？</h2>
<p>在你考慮 CARGO Therapeutics 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場關注之前立即購買……而 CARGO Therapeutics 並不在名單上。</p>
<p>雖然 CARGO Therapeutics 目前在分析師中獲得了 “減持” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

CRGX

<p>CARGO Therapeutics（納斯達克代碼：CRGX）被 HC Wainwright 從 “買入” 評級下調至 “中性” 評級。該公司的平均評級為 “持有”，共識目標價為 15.00 美元。CARGO 的股票開盤價為 13.19 美元，市值為 6.0714 億美元。最近的季度財報顯示每股虧損為（0.88 美元），超出預期。機構投資者持有 93.16% 的股份，儘管評級下調，但仍顯示出強烈的機構興趣</p>

<p>CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) was downgraded by equities research analysts at HC Wainwright from a &#34;buy&#34; rating to a &#34;neutral&#34; rating in a research note issued to investors on Thursday, Marketbeat Ratings reports.</p>
<div class="lb-trans"><p>CARGO Therapeutics（納斯達克代碼：CRGX - 獲取免費報告）在週四發佈給投資者的研究報告中，被 HC Wainwright 的股票研究分析師將評級從 “買入” 下調至 “中性”，Marketbeat Ratings 報道。</p>
</div><p>Get <strong>CARGO Therapeutics</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>CARGO Therapeutics</strong> 的提醒：</p>
</div><ul>
<li>IPO watch 2024: Which new stocks will hit the market?</li>
</ul>
<div class="lb-trans"><ul>
<li>2024 年 IPO 觀察：哪些新股票將上市？</li>
</ul>
</div><p>A number of other equities analysts also recently issued reports on CRGX. Chardan Capital restated a &#34;buy&#34; rating and issued a $28.00 price target on shares of CARGO Therapeutics in a research note on Wednesday, November 13th. William Blair assumed coverage on CARGO Therapeutics in a report on Tuesday, November 26th. They issued an &#34;outperform&#34; rating on the stock. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Hold&#34; and a consensus target price of $15.00.</p>
<div class="lb-trans"><p>其他一些股票分析師最近也對 CRGX 發佈了報告。Chardan Capital 在 11 月 13 日的研究報告中重申了 “買入” 評級，並對 CARGO Therapeutics 的股票設定了 28.00 美元的目標價。William Blair 在 11 月 26 日的報告中開始覆蓋 CARGO Therapeutics，並對該股票給予了 “跑贏大盤” 的評級。一位投資分析師對該股票給予了賣出評級，六位分析師則給予了持有評級。根據 MarketBeat.com 的數據，該公司目前的平均評級為 “持有”，共識目標價為 15.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on CARGO Therapeutics</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 CARGO Therapeutics 的最新研究報告</strong></p>
</div><h2>CARGO Therapeutics Stock Performance</h2>
<div class="lb-trans"><h2>CARGO Therapeutics 股票表現</h2>
</div><p>NASDAQ CRGX opened at $13.19 on Thursday. The company has a market capitalization of $607.14 million, a price-to-earnings ratio of -3.10 and a beta of 2.50. The stock has a 50-day moving average of $14.83 and a 200 day moving average of $17.45. CARGO Therapeutics has a one year low of $10.91 and a one year high of $33.92.</p>
<div class="lb-trans"><p>納斯達克 CRGX 在週四開盤價為 13.19 美元。該公司的市值為 6.0714 億美元，市盈率為-3.10，貝塔值為 2.50。該股票的 50 日移動平均價為 14.83 美元，200 日移動平均價為 17.45 美元。CARGO Therapeutics 的年低為 10.91 美元，年高為 33.92 美元。</p>
</div><p>CARGO Therapeutics (NASDAQ:CRGX - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.88) earnings per share for the quarter, beating the consensus estimate of ($1.14) by $0.26. On average, equities analysts predict that CARGO Therapeutics will post -3.73 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CARGO Therapeutics（納斯達克代碼：CRGX - 獲取免費報告）最近在 11 月 12 日發佈了季度財報。該公司報告季度每股收益為（0.88 美元），超出市場共識預期的（1.14 美元）0.26 美元。股票分析師平均預測 CARGO Therapeutics 在當前財年將發佈-3.73 美元的每股收益。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>A number of hedge funds have recently made changes to their positions in CRGX. FMR LLC lifted its holdings in CARGO Therapeutics by 1.1% during the third quarter. FMR LLC now owns 6,954,476 shares of the company's stock valued at $128,310,000 after purchasing an additional 77,508 shares in the last quarter. RTW Investments LP raised its position in shares of CARGO Therapeutics by 0.5% during the 3rd quarter. RTW Investments LP now owns 4,098,955 shares of the company's stock valued at $75,626,000 after purchasing an additional 20,833 shares during the period. Janus Henderson Group PLC lifted its stake in shares of CARGO Therapeutics by 1.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,675,285 shares of the company's stock valued at $49,335,000 after buying an additional 46,659 shares in the last quarter. Wellington Management Group LLP boosted its holdings in CARGO Therapeutics by 4.1% in the 3rd quarter. Wellington Management Group LLP now owns 2,042,723 shares of the company's stock worth $37,688,000 after buying an additional 79,782 shares during the period. Finally, State Street Corp increased its stake in CARGO Therapeutics by 11.7% in the 3rd quarter. State Street Corp now owns 839,861 shares of the company's stock worth $15,495,000 after buying an additional 88,000 shares in the last quarter. 93.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些對沖基金最近對 CRGX 的持倉進行了調整。FMR LLC 在第三季度將其在 CARGO Therapeutics 的持股增加了 1.1%。FMR LLC 目前擁有 6,954,476 股該公司的股票，價值 1.2831 億美元，此前在上個季度購買了 77,508 股。RTW Investments LP 在第三季度將其在 CARGO Therapeutics 的持倉提高了 0.5%。RTW Investments LP 目前擁有 4,098,955 股該公司的股票，價值 7562.6 萬美元，此前在該期間購買了 20,833 股。Janus Henderson Group PLC 在第三季度將其在 CARGO Therapeutics 的股份增加了 1.8%。Janus Henderson Group PLC 目前擁有 2,675,285 股該公司的股票，價值 4933.5 萬美元，此前在上個季度購買了 46,659 股。Wellington Management Group LLP 在第三季度將其在 CARGO Therapeutics 的持股增加了 4.1%。Wellington Management Group LLP 目前擁有 2,042,723 股該公司的股票，價值 3768.8 萬美元，此前在該期間購買了 79,782 股。最後，State Street Corp 在第三季度將其在 CARGO Therapeutics 的股份增加了 11.7%。State Street Corp 目前擁有 839,861 股該公司的股票，價值 1549.5 萬美元，此前在上個季度購買了 88,000 股。目前 93.16% 的股票由機構投資者持有。</p>
</div><h2>About CARGO Therapeutics</h2>
<div class="lb-trans"><h2>關於 CARGO Therapeutics</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>CARGO Therapeutics, Inc, a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies.</p>
<div class="lb-trans"><p>CARGO Therapeutics, Inc 是一家臨牀階段的生物技術公司，開發用於癌症患者的嵌合抗原受體（CAR）T 細胞療法。該公司的主導項目是 CRG-022，一種自體 CD22 CAR T 細胞產品候選藥物，旨在通過靶向 CD22 這一在 B 細胞惡性腫瘤中表達的替代腫瘤抗原來應對耐藥機制。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than CARGO Therapeutics</li>
<li>Stock Market Sectors: What Are They and How Many Are There?</li>
<li>Kimberly-Clark: A Regal Opportunity in This Dividend King</li>
<li>3 Small Caps With Big Return Potential</li>
<li>5 Stocks With Above-Market Yields Just Raised Payments Further</li>
<li>Using the MarketBeat Dividend Yield Calculator</li>
<li>Arista Networks' Stock Plunge: Buying Opportunity for Investors?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 CARGO Therapeutics</li>
<li>股票市場行業：它們是什麼以及有多少個？</li>
<li>金佰利：在這位股息之王中獲得的絕佳機會</li>
<li>3 只小盤股具有巨大的回報潛力</li>
<li>5 只股票的收益率高於市場，剛剛提高了支付</li>
<li>使用 MarketBeat 股息收益率計算器</li>
<li>Arista Networks 的股票暴跌：投資者的買入機會？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JHWA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CRGX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對本故事有任何問題或意見，請發送電子郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CARGO Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 CARGO Therapeutics 嗎？</h2>
</div><p>Before you consider CARGO Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 CARGO Therapeutics 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CARGO Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦在更廣泛的市場關注之前立即購買……而 CARGO Therapeutics 並不在名單上。</p>
</div><p>While CARGO Therapeutics currently has a &#34;Reduce&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CARGO Therapeutics 目前在分析師中獲得了 “減持” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cargo Therapeutics（納斯達克股票代碼：CRGX）被 HC Wainwright 下調至 “中性” 評級